# Open Label Study to Access Flurpiridaz F18 in PET MPI Verses SPECT MPI

> **NCT01681524** · PHASE3 · WITHDRAWN · sponsor: **Lantheus Medical Imaging**

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DRUG:** Flurpiridaz F18

## Key facts

- **NCT ID:** NCT01681524
- **Lead sponsor:** Lantheus Medical Imaging
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2012-11
- **Primary completion:** 2014-02
- **Final completion:** 2014-05
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** delayed study start
- **Last updated:** 2013-05-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01681524

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01681524, "Open Label Study to Access Flurpiridaz F18 in PET MPI Verses SPECT MPI". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01681524. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*